9969 — InnoCare Pharma Cashflow Statement
0.000.00%
Last trade - 00:00- HK$26.73bn
- HK$20.48bn
- CNY1.01bn
Annual cashflow statement for InnoCare Pharma, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
| Standards: | CAS | CAS | CAS | CAS | CAS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | -126 | -250 | -409 | -562 | -633 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -298 | 167 | -491 | -665 | -366 |
| Capital Expenditures | -229 | -171 | -370 | -255 | -78.2 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -871 | -1,543 | -1,431 | 916 | 1,189 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1,100 | -1,714 | -1,801 | 661 | 1,111 |
| Financing Cash Flow Items | -16.4 | -32.7 | -154 | -38.8 | -166 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2,238 | 2,545 | 3,095 | 1.31 | -286 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 696 | 952 | 942 | 22.6 | 477 |